Abstract: A stent for implantation within the body of a patient is disclosed. The stent can be formed from one or more stent modules comprising a plurality of stent struts, one or more of which have an inner contour designed for streamlined fluid flow when the stent is implanted within an anatomical passageway of the patient.

Abstract: A drug eluting implantable device includes an exterior surface on the device and at least one recess formed in the exterior surface.

Abstract: A method of treating a vascular condition includes applying a plurality of stem cells to an exterior surface of a stent, and enveloping the applied stem cells with a topcoat layer. In addition, the method includes delivering the stent with applied stem cells and topcoat to a treatment region of a vessel within a body; and applying an electrical field to the stent for a predetermined time. A system for treating a vascular condition includes a catheter, a stent disposed on the catheter, at least one layer of stem cells disposed on an exterior surface of the stent, and a topcoat layer surrounding the layer of stem cells. In addition, the system includes at least one electrical lead attached to the stent, the electrical lead operable to induce an electrical field around the stent.

Abstract: A method of treating a vascular condition includes delivering a stent including at least one elongated axial slot to a target region of a vessel and receiving endothelial cell growth in the slots. A system for treating a vascular condition includes a catheter and a stent disposed on the catheter. The stent includes a stent framework including elongated axial slot formed therein and at least one therapeutic agent carried within the elongated axial slots. An outermost surface of the therapeutic agent is recessed within the elongated axial slots from the outer surface of the stent framework to allow endothelial cell growth within the elongated axial slots upon delivery of the stent to a target region of a vessel.

Abstract: A method of manufacturing a drug loaded stent includes applying a photo resistant coating to at least a portion of a stent framework and removing at least a portion of the photo resistant coating from the stent framework. The method further includes applying an etchant to at least a portion of the stent framework and forming a plurality undercut drug reservoirs in the stent framework based on applying the etchant. A stent for treating a vascular condition includes a stent framework, a plurality of undercut reservoirs formed within the stent framework and a therapeutic agent disposed within at least a portion of the plurality of undercut reservoirs.

Abstract: An intraluminal stent, an intraluminal stent delivery system, and a method of treating a vascular condition. The stent includes a framework with a plurality of flap portions projecting substantially beyond a central core region. The flap portions are movable from a compressed position and an extended position when the stent is deployed. The system includes a catheter and the intraluminal stent. The method includes positioning an intraluminal stent within a vessel. A plurality of flap portions of the stent is extended from a compressed position into contact with the vessel.

Abstract: An intraluminal stent, an intraluminal stent delivery system, and a method treating a vascular condition. The stent includes a framework including an elongated spiral seam. The framework includes a side edge including an angle formed with respect to an end edge. The system includes a catheter and a stent. The stent includes a framework including an elongated spiral seam. The framework includes a side edge including an angle formed with respect to an end edge. The method includes positioning a stent including at least one spiral seam at a target region of a vessel. The stent is expanded from a compressed configuration to a deployed configuration. At least one therapeutic agent is delivered from the stent along the at least one spiral seam.